NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

TSX · Drug Manufacturers - Specialty & Generic · CAD

Avant Brands Inc. (AVNT.TO) Stock Analysis

Avant Brands Inc. (AVNT.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.

AVNT.TO

CA$0.70

+CA$0.13 (+22.81%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AVNT.TO with… →

AVNT.TO Key Statistics

As of Sep 4, 2026
Trading
Open
CA$0.57
Previous Close
CA$0.57
Day's Range
0.55–0.70
52-Week Range
0.48–1.07
Volume
25.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.46
Valuation
Market Cap
CA$10.55M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.31
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.88
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
−35.07%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
15.07M
1-Year Return
−15.66%
Dividend and dates
Earnings Date
October 15, 2026estimated
Avg Volume
6.52K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AVNT.TO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−22.22%
2025+73.08%
2024−87.62%
2023−15.15%
2022−52.86%
2021+233.33%
2020−48.78%
2019−58.16%
2018 (partial year)−65.00%

As of September 4, 2026.

AVNT.TO Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 103 stocks
MetricAVNT.TODrug Manufacturers - Specialty & Generic medianvs median
P/S ratio0.312.300.1x the median
Profit margin−35.07%−3.14%31.9 pts below

Medians across 103 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Avant Brands Inc. (AVNT.TO) at CA$10.55M. It is classified in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector. The company reports 180 employees.

The most recent close on file for AVNT.TO is CA$0.70, dated September 4, 2026. That is +CA$0.13 (+22.81%) against the previous close. Over the past 52 weeks the price has ranged from CA$0.48 to CA$1.07. The latest close sits 45.83% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is CA$33.64M. The reported profit margin is −35.07%. That is 31.9 percentage points below the Drug Manufacturers - Specialty & Generic median of −3.14%. Trailing earnings per share are −0.88.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.31. On price-to-sales that is 0.1 times the Drug Manufacturers - Specialty & Generic median of 2.3. 103 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −15.66%. Measured over 5 years, that is −48.11% a year compounded. The reported beta is 1.46. Daily returns over the trailing 8 years annualize to a volatility of 98.06%.

Growth & Income

No dividend is on file for AVNT.TO.

The strongest complete calendar year on file is 2021 at +233.33%; the weakest is 2024 at −87.62%. Of the 7 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −22.22% year to date.

Peer Comparison

Avant Brands Inc. (AVNT.TO) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Avant Brands Inc. AVNT.TO CA$10.55M —
Takeda Pharmaceutical Company Limited TAK CA$58.92B —
Teva Pharmaceutical Industries Limited TEVA CA$42.37B 60.6
Haleon plc HLN CA$42.22B 20.0

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 19.3x. Avant Brands Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

TAK

Takeda Pharmaceutical Company Limited

$58.92B

 TEVA

Teva Pharmaceutical Industries Limited

$42.37B

 HLN

Haleon plc

$42.22B

 ZTS

Zoetis Inc.

$31.33B

 UTHR

United Therapeutics Corporation

$20.91B

 VTRS

Viatris Inc.

$19.39B
View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Avant Brands Inc.

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada. The company offers recreational cannabis products under the BLK MKT, Tenzo, Cognoscente, Treehugger, Pristine, and Flowr brands. It also provides medical cannabis products under the GreenTec brand. The company distributes cannabis through medical and recreational sales channels, as well as an e-commerce website. It also exports its products through the wholesale channel. The company was formerly known as GTEC Holdings Ltd. and changed its name to Avant Brands Inc. in July 2021. Avant Brands Inc. is headquartered in Kelowna, Canada.

Visit website →